Skip to main content
. 2018 May 21;12(7):1125–1137. doi: 10.1002/1878-0261.12315

Figure 4.

Figure 4

Performance assessment of the six‐miRNA signature by survival ROC analysis. ROC analysis of the six‐miRNA signature for prediction of recurrence risk at 1, 3, and 5 years in the training set (A), the testing set (B), and the entire set (C).